Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Health Italia SpA's revenue for the
six
months ended in Jun. 2025 was €20.60 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2025 was €37.73 Mil.
Health Italia SpA's Revenue per Share for the
six
months ended in Jun. 2025 was €108.43.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2025 was €198.56.
Warning Sign:
Health Italia SpA revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of Health Italia SpA was 0.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -3.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -30.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 10 years, Health Italia SpA's highest 3-Year average Revenue per Share Growth Rate was 25.60% per year. The lowest was -77.80% per year. And the median was 4.60% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Health Italia SpA Revenue Related Terms
Health Italia SpA Revenue Historical Data
* Premium members only.
The historical data trend for Health Italia SpA's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Health Italia SpA's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Italia SpA Revenue vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Health Italia SpA's Revenue distribution charts can be found below:
* The bar in red indicates where Health Italia SpA's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €37.73 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Italia SpA (MIL:HI) has a Revenue of €37.73 Mil as of Jun. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Health Italia SpA and its competitors.
Is Health Italia SpA's Revenue too high?
Health Italia SpA's current Revenue is €37.73 Mil. Overall, Health Italia SpA has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Health Italia SpA's Revenue compare to UNH and CVS?
Health Italia SpA's Revenue of €37.73 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Healthcare Plans company?
A good Revenue depends on the Healthcare Plans industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Health Italia SpA and its competitors. Health Italia SpA's current Revenue is €37.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Italia SpA stock overvalued right now?
Health Italia SpA (MIL:HI) has a current Revenue of €37.73 Mil. The stock's GF Value™ is €142.57, compared to a current price of €299.00 — trading 109.7% above its estimated fair value. The current Revenue is €37.73 Mil. Health Italia SpA's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Health Italia SpA (MIL:HI), the current Revenue is €37.73 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health Italia SpA (MIL:HI) Overvalued in 2026?
Based on GuruFocus' analysis, Health Italia SpA stock appears to be overvalued.
The current stock price of €299.00 is trading 109.7% above its estimated GF Value™ of €142.57.
Key valuation signals for MIL:HI:
Revenue: €37.73 Mil
GF Value™: €142.57 vs. price of €299.00 (109.7% above fair value)
No single metric tells the full story. See the MIL:HI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health Italia SpA is an Italy based company engaged in offering integrated healthcare services. It operates in the promotion of integrated and alternative healthcare solutions and provides administrative, liquidation, information technology and consulting services for health funds, health care funds and mutual-aid companies. In addition, the group is also active in the corporate welfare market and manages outsourced flexible benefit welfare plans.
43GF Score
Get the complete analysis for MIL:HI
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:HI has been successfully added to your 
